NCR Voyix Corporation (LON:0K45)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,346	1,614	1,875	2,670	3,913	3,547
Market Cap Growth	-27.37%	-13.92%	-29.78%	-31.78%	10.32%	4.71%
Enterprise Value	2,133	2,277	7,712	7,570	8,346	6,297
Last Close Price	9.98	11.14	13.28	11.87	18.16	16.64
PE Ratio	1.80	2.14	-	73.10	65.41	-
PS Ratio	0.64	0.72	0.75	1.01	1.44	0.78
PB Ratio	1.53	1.67	7.93	1.83	3.46	3.66
P/FCF Ratio	-	-	4.23	9.60	5.87	7.94
P/OCF Ratio	-	-	3.44	7.53	5.25	7.56
EV/Sales Ratio	1.03	1.01	3.09	2.87	3.06	1.39
EV/EBITDA Ratio	9.61	12.34	23.17	16.09	24.84	22.45
EV/EBIT Ratio	37.18	39.04	9823.69	115.45	132.95	45.25
EV/FCF Ratio	-16.31	-	17.42	27.23	12.51	14.10
Debt / Equity Ratio	1.18	1.16	9.58	3.42	3.96	2.81
Debt / EBITDA Ratio	4.56	4.44	5.55	8.97	10.53	6.90
Debt / FCF Ratio	-	-	5.11	17.92	6.73	6.11
Asset Turnover	0.59	0.60	0.39	0.27	0.37	0.71
Inventory Turnover	8.90	9.63	8.10	4.43	4.04	6.76
Quick Ratio	0.81	0.89	0.51	0.28	0.50	0.70
Current Ratio	1.12	1.18	0.91	1.14	1.02	1.19
Return on Equity (ROE)	-22.14%	-26.92%	-70.95%	-22.45%	-23.59%	-0.43%
Return on Assets (ROA)	1.02%	0.97%	0.01%	0.43%	0.53%	1.36%
Return on Capital (ROIC)	1.68%	1.57%	0.01%	0.64%	0.84%	2.24%
Return on Capital Employed (ROCE)	2.60%	2.40%	0.00%	0.90%	1.00%	3.00%
Earnings Yield	55.56%	47.42%	-17.72%	1.86%	1.83%	-1.63%
FCF Yield	-9.72%	-8.02%	23.62%	10.42%	17.04%	12.60%
Payout Ratio	1.53%	1.57%	-	25.00%	15.46%	-
Buyback Yield / Dilution	-1.57%	-2.92%	-2.85%	-4.19%	-2.18%	11.57%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.